申请人:Farmitalia Carlo Erba S.p.A.
公开号:US04267327A1
公开(公告)日:1981-05-12
2-Hydroxymethyl-pyrazine derivatives are disclosed, such as, for instance, the compound 2-hydroxymethyl-5-methylpyrazine-4-oxide. The compounds exhibit an elevated lipid lowering activity, and can be used to control triglyceride and cholesterol levels.
本文披露了2-羟甲基吡嗪衍生物,例如2-羟甲基-5-甲基吡嗪-4-氧化物。这些化合物表现出升高的降脂活性,可用于控制甘油三酯和胆固醇水平。